Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill has maintained a 'Buy' rating on HealthEquity (NASDAQ:HQY) and raised the price target from $71 to $72.
September 07, 2023 | 3:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank has maintained a 'Buy' rating on HealthEquity and raised the price target from $71 to $72.
The 'Buy' rating maintained by Deutsche Bank indicates a positive outlook for HealthEquity. The increase in price target from $71 to $72 suggests that the analyst sees potential for the stock's price to increase, which could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100